DrugJun 22, 2022
SUN PHARMACEUTICAL INDUSTRIES medroxyPROGESTERone Acetate Injectable Suspension, USP, 25 x 1 recall — FDA D-1147-2022
Lack of assurance of sterility
Class IIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
10,685drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 92
10,685 detailed records are currently available in this category.
DrugJun 22, 2022
Lupin Pharmaceuticals Zileuton Extended-Release Tablets, 600 mg, 120-count bottle recall — FDA D-1150-2022
Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.
Class IIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugJun 22, 2022
medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL recall — FDA D-1145-2022
Lack of assurance of sterility
Class IIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
DrugJun 22, 2022
A.P. Nonweiler Alcohol Antiseptic 80%, Topical Solution, Hand Sanitizer, Non-Sterile recall — FDA D-1142-2022
CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.
Class IIFDA: OngoingA.P. Nonweiler
DrugJun 22, 2022
SUN PHARMACEUTICAL INDUSTRIES medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL recall — FDA D-1146-2022
Lack of assurance of sterility
Class IIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
DrugJun 22, 2022
Walmart Artri King Reforzado con Ortiga Omega 3 Tablets, ORIGINAL, 100-count bottles recall — FDA D-1157-2022
Marketed Without An Unapproved NDA/ANDA: Product lot found to be tainted with undeclared diclofenac, an FDA approved nonsteroidal anti-inflammatory drug (NSAID) for the treatment of pain…
Class IFDA: CompletedWalmart Inc.
DrugJun 22, 2022
AMS Packaging Premium Nature Instant Hand Sanitizer, (ethyl alcohol 65%), 8 oz/ 236 ML recall — FDA D-1148-2022
Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol.
Class IIFDA: OngoingAMS Packaging Inc.
DrugJun 22, 2022
HAND SANITIZER SAY GOODBYE TO GERMS Alcohol Antiseptic 80% Topical Non-Sterile Solution, 12 recall — FDA D-1149-2022
CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.
Class IIFDA: TerminatedHand Sanitizer LLC
DrugJun 22, 2022
SUN PHARMACEUTICAL INDUSTRIES medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL recall — FDA D-1143-2022
Lack of assurance of sterility
Class IIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
DrugJun 22, 2022
Washington Homeopathic Products Candida Albicans, Potency: 9C, 10C, 12C, 13C, 14C 15C 16C recall — FDA D-1127-2022
cGMP deviations
Class IIFDA: TerminatedWashington Homeopathic Products, Inc.
DrugJun 15, 2022
Teva Pharmaceuticals USA Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 recall — FDA D-0988-2022
Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing
Class IIIFDA: TerminatedTeva Pharmaceuticals USA Inc.
DrugJun 15, 2022
US Specialty Formulations B-Complex + Chromic Chloride recall — FDA D-0987-2022
Lack of Assurance of Sterility
Class IIFDA: TerminatedUS Specialty Formulations LLC
DrugJun 15, 2022
Novartis Pharmaceuticals Xiidra recall — FDA D-0985-2022
Failed Impurities/Degradation Specifications.
Class IIIFDA: TerminatedNovartis Pharmaceuticals Corporation
DrugJun 15, 2022
Recothrom Thrombin Topical (Recombinant), 5,000 units recall — FDA D-1082-2022
cGMP deviations: Temperature abuse
Class IIFDA: TerminatedMckesson Medical-Surgical Inc. Corporate Office
DrugJun 15, 2022
Xiidra recall — FDA D-0984-2022
Failed Impurities/Degradation Specifications.
Class IIIFDA: TerminatedNovartis Pharmaceuticals Corporation
DrugJun 15, 2022
Mckesson Medical-Surgical Inc. Corporate Office Propofol Injectable Emulsion, USP, 200 mg/ recall — FDA D-1077-2022
cGMP deviations: Temperature abuse
Class IIFDA: TerminatedMckesson Medical-Surgical Inc. Corporate Office
DrugJun 15, 2022
Novartis Pharmaceuticals Xiidra recall — FDA D-0983-2022
Failed Impurities/Degradation Specifications.
Class IIIFDA: TerminatedNovartis Pharmaceuticals Corporation
DrugJun 15, 2022
Xiidra recall — FDA D-0982-2022
Failed Impurities/Degradation Specifications.
Class IIIFDA: TerminatedNovartis Pharmaceuticals Corporation
DrugJun 8, 2022
Nephron Sterile Compounding Center Calcium Gluconate Injection, USP 10%, 0.465 mEq Ca++/mL recall — FDA D-0951-2022
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugJun 8, 2022
Nephron Sterile Compounding Center Epinephrine Injection, USP, 1 mg/10 mL (100 mcg/mL), 10 recall — FDA D-0953-2022
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugJun 8, 2022
Nephron Sterile Compounding Center Phenylephrine HCl Injection, USP, 0.4 mg/10 mL recall — FDA D-0965-2022
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugJun 8, 2022
Nephron Sterile Compounding Center Neostigmine Methylsulfate Injection, USP, 5 mg/5 mL recall — FDA D-0963-2022
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugJun 8, 2022
Nephron Sterile Compounding Center Glycopyrrolate Injection, USP, 0.6 mg/3 mL (0.2 mg/mL) recall — FDA D-0956-2022
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugJun 8, 2022
Nephron Sterile Compounding Center Hydromorphone HCl Injection, USP, 6 mg/30 mL (0.2 mg/mL) recall — FDA D-0958-2022
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.